BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15599014)

  • 1. "Do-nothing" alternative and cost-minimization evaluations.
    Agarwal KS
    Indian J Gastroenterol; 2004; 23(5):194; author reply 194-5. PubMed ID: 15599014
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining the point of indifference--where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise.
    Varghese RM; Abraham J; James J; Puliyel JM
    Indian J Gastroenterol; 2004; 23(4):154-6. PubMed ID: 15333982
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial factors that influence cost-effectiveness of universal hepatitis B immunization in India.
    Prakash C
    Int J Technol Assess Health Care; 2003; 19(1):28-40. PubMed ID: 12701937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Shouval D
    J Epidemiol Community Health; 1992 Dec; 46(6):587-94. PubMed ID: 1494073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B control: to vaccinate or not.
    Peshwe HB; Mohandas KM
    Indian J Gastroenterol; 2004; 23(3):116-7; author reply 117. PubMed ID: 15250578
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma-derived and recombinant hepatitis B vaccines.
    John TJ
    Indian Pediatr; 1997 Aug; 34(8):745-6. PubMed ID: 9492408
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of hepatitis B virus immunization.
    Sharfstein J; Wise P
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598611
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of hepatitis B virus immunization.
    Everett WD
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598610
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of hepatitis B virus immunization.
    Watters JK; Kral AH
    JAMA; 1996 Mar; 275(12):907-8. PubMed ID: 8598609
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of hepatitis B virus immunization.
    Edmunds WJ; Medley GF; Nokes DJ
    JAMA; 1996 Mar; 275(12):907; author reply 909. PubMed ID: 8598608
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effective trauma implant selection: AAOS exhibit selection.
    Egol KA; Capriccioso CE; Konda SR; Tejwani NC; Liporace FA; Zuckerman JD; Davidovitch RI
    J Bone Joint Surg Am; 2014 Nov; 96(22):e189. PubMed ID: 25410517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value-based Healthcare: Increasing Value by Reducing Implant-related Health Care Costs.
    Waldrop VH; Laverty DC; Bozic KJ
    Clin Orthop Relat Res; 2019 Feb; 477(2):281-283. PubMed ID: 29762154
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of hepatitis B vaccine in The Gambia.
    Hall AJ; Roberston RL; Crivelli PE; Lowe Y; Inskip H; Snow SK; Whittle H
    Trans R Soc Trop Med Hyg; 1993; 87(3):333-6. PubMed ID: 8236411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating prescribing interventions.
    Wong G
    Br J Gen Pract; 2002 May; 52(478):412-3. PubMed ID: 12014546
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 18. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desirability and feasibility of hepatitis B vaccine in EPI.
    Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.